Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial

10.1016/j.antiviral.2012.07.008

Saved in:

Bibliographic Details
Main Authors:	Watanabe, S., Rathore, A.P.S., Sung, C., Lu, F., Khoo, Y.M., Connolly, J., Low, J., Ooi, E.E., Lee, H.S., Vasudevan, S.G.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2014
Subjects:	AG129 lethal infection mouse model Antiviral Dengue virus Pharmacokinetics
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/110037
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-110037
record_format	dspace
spelling	sg-nus-scholar.10635-1100372024-11-13T03:42:24Z Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial Watanabe, S. Rathore, A.P.S. Sung, C. Lu, F. Khoo, Y.M. Connolly, J. Low, J. Ooi, E.E. Lee, H.S. Vasudevan, S.G. DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE AG129 lethal infection mouse model Antiviral Dengue virus Pharmacokinetics 10.1016/j.antiviral.2012.07.008 Antiviral Research 96 1 32-35 ARSRD 2014-11-26T08:27:50Z 2014-11-26T08:27:50Z 2012-10 Article Watanabe, S., Rathore, A.P.S., Sung, C., Lu, F., Khoo, Y.M., Connolly, J., Low, J., Ooi, E.E., Lee, H.S., Vasudevan, S.G. (2012-10). Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial. Antiviral Research 96 (1) : 32-35. ScholarBank@NUS Repository. https://doi.org/10.1016/j.antiviral.2012.07.008 01663542 http://scholarbank.nus.edu.sg/handle/10635/110037 000310668000004 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	AG129 lethal infection mouse model Antiviral Dengue virus Pharmacokinetics
spellingShingle	AG129 lethal infection mouse model Antiviral Dengue virus Pharmacokinetics Watanabe, S. Rathore, A.P.S. Sung, C. Lu, F. Khoo, Y.M. Connolly, J. Low, J. Ooi, E.E. Lee, H.S. Vasudevan, S.G. Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial
description	10.1016/j.antiviral.2012.07.008
author2	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
author_facet	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE Watanabe, S. Rathore, A.P.S. Sung, C. Lu, F. Khoo, Y.M. Connolly, J. Low, J. Ooi, E.E. Lee, H.S. Vasudevan, S.G.
format	Article
author	Watanabe, S. Rathore, A.P.S. Sung, C. Lu, F. Khoo, Y.M. Connolly, J. Low, J. Ooi, E.E. Lee, H.S. Vasudevan, S.G.
author_sort	Watanabe, S.
title	Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial
title_short	Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial
title_full	Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial
title_fullStr	Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial
title_full_unstemmed	Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial
title_sort	dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/110037
_version_	1821216693942222848

Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial

Similar Items